AESKULISA ANA HEP-2— 510(k) K040953

Substantially Equivalent

Aesku, Inc.

FDA 510(k) clearance K040953 for AESKULISA ANA HEP-2, Substantially Equivalent on 2004-06-23. Applicant: Aesku, Inc.. Device class: 2.

Clearance details

Applicant: Aesku, Inc.
Product code: Code LJM
Device class: Class 2
Regulation: 21 CFR 866.5100
Advisory panel: Immunology
Date received: 2004-04-12
Decision date: 2004-06-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Miami, FL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LJM

K182353 — EliA CENP Immunoassay, EliA U1RNP Immunoassay, EliA RNP70 Immunoassay2018-11-27
K151559 — ImmuLisa Enhanced Centromere Antibody ELISA2016-03-11
K140493 — ELIA SCL-70S IMMUNOASSAY2014-10-30
K123880 — QUANTA FLASH CENTROMERE2014-02-07
K131330 — GOLD STANDARD DIAGNOSTICS ANTI-NUCLEAR ANTIBODY (ANA) SCREEN ELISA TEST KIT2014-01-28

More clearances from Aesku, Inc.

K062217 — AESKULSKA BETA2-GLYCO-A2006-12-13
K051492 — AESKULISA ASCA A2005-11-14
K042644 — AESKULISA TTG A AND AESKULISA TTG G2005-06-01
K040463 — AESKULISA CARDIOLIPIN AGM2004-05-12
K032469 — AESKULISA ANA 8PRO2003-12-16

Data sourced from openFDA. This site is unofficial and independent of the FDA.